Hyperphosphatemia Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Novel Therapeutics and Rising CKD Burden | DelveInsight

The hyperphosphatemia market is projected to witness steady growth, driven by the increasing global prevalence of chronic kidney disease, diabetes, and hypertension, along with a growing dialysis patient population. Additionally, the emergence of novel therapies such as TS-172 (Taisho...